{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:07:46Z","timestamp":1791472066788,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["13SDG17230049"],"award-info":[{"award-number":["13SDG17230049"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15SDG24470155"],"award-info":[{"award-number":["15SDG24470155"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002584","name":"American Historical Association","doi-asserted-by":"publisher","award":["T32 GM008353"],"award-info":[{"award-number":["T32 GM008353"]}],"id":[{"id":"10.13039\/100002584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002584","name":"American Historical Association","doi-asserted-by":"publisher","award":["15PRE25090050"],"award-info":[{"award-number":["15PRE25090050"]}],"id":[{"id":"10.13039\/100002584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002584","name":"American Historical Association","doi-asserted-by":"publisher","award":["16POST27760002"],"award-info":[{"award-number":["16POST27760002"]}],"id":[{"id":"10.13039\/100002584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002584","name":"American Historical Association","doi-asserted-by":"publisher","award":["T32 HL125242"],"award-info":[{"award-number":["T32 HL125242"]}],"id":[{"id":"10.13039\/100002584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM113832"],"award-info":[{"award-number":["GM113832"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL068878"],"award-info":[{"award-number":["HL068878"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL134569"],"award-info":[{"award-number":["HL134569"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS091555"],"award-info":[{"award-number":["NS091555"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ebiom.2017.12.021","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T03:06:07Z","timestamp":1513739167000},"page":"225-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression"],"prefix":"10.1016","volume":"28","author":[{"given":"Yanhong","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenmin","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Kuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily E.","family":"Morin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minerva T.","family":"Garcia-Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schwendeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Eugene Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2017.12.021_bb0005","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1194\/jlr.M700274-JLR200","article-title":"The roles of different pathways in the release of cholesterol from macrophages","volume":"48","author":"Adorni","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0010","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/01.ATV.0000014804.35824.DA","article-title":"Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages","volume":"22","author":"Aiello","year":"2002","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0015","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1161\/01.STR.0000147036.07307.93","article-title":"ABCA1 expression in carotid atherosclerotic plaques","volume":"35","author":"Albrecht","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0020","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.CIR.0000066913.69844.B2","article-title":"Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia","volume":"107","author":"Belalcazar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/eurheartj\/ehs376","article-title":"ABCA1 mutation carriers with low high-density lipoprotein cholesterol are characterized by a larger atherosclerotic burden","volume":"34","author":"Bochem","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0030","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.atherosclerosis.2011.04.001","article-title":"The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins","volume":"217","author":"DI Bartolo","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0035","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1038\/ncomms4065","article-title":"A statin-loaded reconstituted high-density lipoprotein nanoparticle inhibits atherosclerotic plaque inflammation","volume":"5","author":"Duivenvoorden","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0040","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1172\/JCI79048","article-title":"Perhexiline activates KLF14 and reduces atherosclerosis by modulating Apo A-I production","volume":"125","author":"Guo","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0045","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/01.ATV.16.1.4","article-title":"Development of the lipid-rich core in human atherosclerosis","volume":"16","author":"Guyton","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0050","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/MOL.0000000000000050","article-title":"Reverse cholesterol transport fluxes","volume":"25","author":"Hellerstein","year":"2014","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0055","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.bbalip.2011.08.009","article-title":"Synthetic LXR agonist inhibits the development of atherosclerosis in New Zealand White rabbits","volume":"1811","author":"Honzumi","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0060","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/CIRCRESAHA.110.226878","article-title":"Liver x receptors in atherosclerosis and inflammation","volume":"108","author":"Im","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0065","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Investigators","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.atherosclerosis.2011.05.029","article-title":"Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide\/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits","volume":"218","author":"Iwata","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0075","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0080","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1073\/pnas.112059299","article-title":"Synthetic LXR ligand inhibits the development of atherosclerosis in mice","volume":"99","author":"Joseph","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0085","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.012587699","article-title":"The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL\/6 and apoE-knockout mice","volume":"99","author":"Joyce","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0090","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nmat4822","article-title":"Designer vaccine nanodiscs for personalized cancer immunotherapy","volume":"16","author":"Kuai","year":"2017","journal-title":"Nat. Mater."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/bbrc.1999.0406","article-title":"Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages","volume":"257","author":"Langmann","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0100","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1021\/acs.bioconjchem.5b00203","article-title":"Targeted delivery of LXR agonist using a site-specific antibody-drug conjugate","volume":"26","author":"Lim","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0105","first-page":"10","article-title":"Multimodality Intracoronary Imaging With Near-Infrared Spectroscopy and Intravascular Ultrasound in Asymptomatic Individuals With High Calcium Scores","author":"Madder","year":"2017","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0110","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/FJC.0b013e318167141f","article-title":"Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway","volume":"51","author":"Qiu","year":"2008","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0115","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1021\/bc500517k","article-title":"HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages","volume":"26","author":"Sanchez-Gaytan","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0120","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.850400","article-title":"Role of LXRs in control of lipogenesis","volume":"14","author":"Schultz","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0125","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0130","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1194\/jlr.M060285","article-title":"The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties","volume":"56","author":"Schwendeman","year":"2015","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0135","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jcmg.2016.06.017","article-title":"Carotid plaque lipid content and fibrous cap status predict systemic CV outcomes: the MRI substudy in AIM-HIGH","volume":"10","author":"Sun","year":"2017","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0140","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1194\/jlr.M071043","article-title":"Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization","volume":"58","author":"Tang","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0145","doi-asserted-by":"crossref","first-page":"11896","DOI":"10.1073\/pnas.182199799","article-title":"Identification of macrophage liver X receptors as inhibitors of atherosclerosis","volume":"99","author":"Tangirala","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137584","article-title":"HDL and CER-001 inverse-dose dependent inhibition of atherosclerotic plaque formation in apoE\u2212\/\u2212 mice: evidence of ABCA1 down-regulation","volume":"10","author":"Tardy","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0155","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0014-5793(02)03578-0","article-title":"T-0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor-deficient mice","volume":"536","author":"Terasaka","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0160","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1161\/ATVBAHA.108.175257","article-title":"Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice","volume":"28","author":"Teupser","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0165","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1161\/01.ATV.0000208364.22732.16","article-title":"Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice","volume":"26","author":"VAN Eck","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0170","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.ATV.21.1.13","article-title":"High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport","volume":"21","author":"VON Eckardstein","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0022-2275(20)33893-1","article-title":"Apo A-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apo B transgenic mice","volume":"39","author":"Voyiaziakis","year":"1998","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0180","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/ATVBAHA.107.146068","article-title":"In vivo reverse cholesterol transport from macrophages lacking ABCA1 expression is impaired","volume":"27","author":"Wang","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0185","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1161\/01.ATV.0000148707.93054.7d","article-title":"Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux","volume":"24","author":"Wong","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0190","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.atherosclerosis.2007.03.030","article-title":"The effect of statins on ABCA1 and ABCG1 expression in human macrophages is influenced by cellular cholesterol levels and extent of differentiation","volume":"196","author":"Wong","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0021-9150(01)00724-9","article-title":"Apolipoprotein A-I deficiency with accumulated risk for CHD but no symptoms of CHD","volume":"162","author":"Yokota","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ebiom.2017.12.021_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700313","article-title":"Targeted nanotherapeutics encapsulating liver x receptor agonist gw3965 enhance antiatherogenic effects without adverse effects on hepatic Lipid metabolism in Ldlr\u2212\/\u2212 mice","volume":"6","author":"Yu","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0205","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1124\/jpet.105.093930","article-title":"Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP","volume":"317","author":"Zanotti","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ebiom.2017.12.021_bb0210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/01.CIR.0000086981.09834.E0","article-title":"Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo","volume":"108","author":"Zhang","year":"2003","journal-title":"Circulation"}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396417305029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396417305029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T18:48:37Z","timestamp":1762454917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396417305029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":42,"alternative-id":["S2352396417305029"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2017.12.021","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2017.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}